Literature DB >> 8500797

Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat.

J K Tarlow1, A I Blakemore, A Lennard, R Solari, H N Hughes, A Steinkasserer, G W Duff.   

Abstract

We have investigated the polymorphism in intron 2 of the interleukin-1 receptor antagonist gene and identified two new alleles of the system. We have shown that the polymorphism is caused by the variable copy number of an 86-bp sequence, by using the polymerase chain reaction and primers immediately flanking the repeat region, and by direct sequencing. The repeat region contains three potential protein-binding sites and therefore the variable copy number may have functional significance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8500797     DOI: 10.1007/BF00217368

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  5 in total

1.  Reversible silencing of enhancers by sequences derived from the human IFN-alpha promoter.

Authors:  D Kuhl; J de la Fuente; M Chaturvedi; S Parimoo; J Ryals; F Meyer; C Weissmann
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

2.  Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter.

Authors:  H Hug; M Costas; P Staeheli; M Aebi; C Weissmann
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

Review 3.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.

Authors:  C A Dinarello; R C Thompson
Journal:  Immunol Today       Date:  1991-11

4.  Length variation within intron 2 of the human IL-1 receptor antagonist protein gene (IL1RN).

Authors:  A Steinkasserer; K Koelble; R B Sim
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

5.  Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene.

Authors:  A Lennard; P Gorman; M Carrier; S Griffiths; H Scotney; D Sheer; R Solari
Journal:  Cytokine       Date:  1992-03       Impact factor: 3.861

  5 in total
  126 in total

1.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta after live yellow fever vaccination.

Authors:  U T Hacker; S Erhardt; K Tschöp; T Jelinek; S Endres
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

3.  Genetics of the bone response to bisphosphonate treatments.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

4.  Gene-gene interaction between tuberculosis candidate genes in a South African population.

Authors:  Erika de Wit; Lize van der Merwe; Paul D van Helden; Eileen G Hoal
Journal:  Mamm Genome       Date:  2010-08-27       Impact factor: 2.957

5.  Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers.

Authors:  L Joos; L McIntyre; J Ruan; J E Connett; N R Anthonisen; T D Weir; P D Paré; A J Sandford
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

6.  A functional polymorphism in the interleukin-1 receptor-1 gene is associated with increased risk of Helicobacter pylori infection but not with gastric cancer.

Authors:  Steve Hartland; Julia L Newton; S Michael Griffin; Pete T Donaldson
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

7.  The course of gastric cancer following surgery is associated with genetic variations of the interleukin-1 receptor antagonist and interleukin-1β.

Authors:  Anke H van der Ploeg; Oliver Kumpf; Evelyn Seelow; Luis C Berrocal Almanza; Peter M Schlag; Ralf R Schumann; Lutz Hamann
Journal:  Gastric Cancer       Date:  2014-02-21       Impact factor: 7.370

8.  Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation.

Authors:  Alexander P Reiner; Mark M Wurfel; Leslie A Lange; Christopher S Carlson; Alex S Nord; Cara L Carty; Mark J Rieder; Cindy Desmarais; Nancy S Jenny; Carlos Iribarren; Jeremy D Walston; O Dale Williams; Deborah A Nickerson; Gail P Jarvik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-05-01       Impact factor: 8.311

9.  Genetic analysis of interleukin-1 receptor antagonist and interleukin-1β single-nucleotide polymorphisms C-511T and C+3953T in alopecia areata: susceptibility and severity association.

Authors:  Suad Alfadhli; Arti Nanda
Journal:  Clin Exp Med       Date:  2013-04-13       Impact factor: 3.984

10.  Circulating IL-1beta levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women.

Authors:  Nianfeng Qian; Xiaojun Chen; Suping Han; Fulin Qiang; Guangfu Jin; Xiaoyi Zhou; Jing Dong; Xinru Wang; Hongbing Shen; Zhibin Hu
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-11       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.